
Controlled Environments
GMP Annex 1 · AEMPS · EMA · FDA · Full DQ/IQ/OQ/PQ
GMP environments with the full Contamination Control Strategy required by the revised Annex 1.
In detail
Building a pharmaceutical cleanroom is necessary. Passing a regulatory inspection is the real objective. Our GMP environments deliver the complete Contamination Control Strategy (CCS) required by the revised Annex 1 (EU, 2022): pressure cascades, segregation of personnel and material flows, validated gowning architecture, certifiable surface finishes. ICH Q7 for active pharmaceutical ingredients. ICH Q9 for risk management. GMP Annex 15 for qualification and validation. DQ/IQ/OQ/PQ as a standard deliverable.
Regulatory framework covered: Regulation (EU) 2023/1182 and GMP Annex 1, EMA guidelines, FDA 21 CFR Parts 210 and 211. For Spanish-speaking markets: AEMPS (Spain), COFEPRIS (Mexico), ANMAT (Argentina) and INVIMA (Colombia) — all with abbreviated pathways that recognise EMA and FDA as authorisation references. One documentation set. Every market.